严重喘和生物疗法:现在和未来
Olaia Sardon-Prado1,2, Carolina Diaz-Garcia3, Paula Corcuera-Elosegui1
1Division of Paediatric Respiratory Medicine, Donostia University Hospital, 20014 San Sebastián, Spain.
Journal of clinical medicine
|September 28, 2023
概括
针对儿科喘的个性化药物正在推进针对特定内型的生物疗法. 本综述涵盖了生物药物,它们的机制,疗效和儿童严重喘的生物标志物.
科学领域:
- 儿科肺病学 儿科肺病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 儿科喘的表型变化需要个性化治疗策略.
- 了解喘内型和生物标志物对于推进治疗方法至关重要.
- 生物疗法对于治疗严重儿科喘越来越重要.
研究的目的:
- 审查儿童严重喘生物药物的作用机制,疗效和生物标志物.
- 为了比较严重喘儿童可用的生物疗法.
- 为了突出美国食品和药物管理局 (FDA) 和欧洲药品管理局 (EMA) 在监管批准方面的差异.
主要方法:
- 对儿科严重喘的生物疗法进行文献综述.
- 对药物机制,疗效数据和生物标志物研究的分析.
- 对选定的生物制剂的FDA和EMA批准标准的比较.
主要成果:
- T2喘表型在儿童中最常见;非T2表型更为罕见.
- 目前可用的生物药物包括奥马利祖马布,梅波利祖马布,本拉利祖马布,杜皮卢马布和特泽佩卢马布.
- 预测和监测治疗反应的生物标志物正在研究中.
结论:
- 生物疗法为儿童严重喘提供了有前途的个性化治疗选择.
- 对内型和生物标志物的进一步研究将完善治疗策略.
- 导航不同的监管批准对于临床实施至关重要.
相关概念视频
Asthma: Pathogenesis and Management
433
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
433
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
326
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
326
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K


